Ndiritu Moses, Cowgill Karen D, Ismail Amina, Chiphatsi Salome, Kamau Tatu, Fegan Gregory, Feikin Daniel R, Newton Charles R J C, Scott J Anthony G
Wellcome Trust/Kenya Medical Research Institute, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya.
BMC Public Health. 2006 May 17;6:132. doi: 10.1186/1471-2458-6-132.
Kenya introduced a pentavalent vaccine including the DTP, Haemophilus influenzae type b and hepatitis b virus antigens in Nov 2001 and strengthened immunization services. We estimated immunization coverage before and after introduction, timeliness of vaccination and risk factors for failure to immunize in Kilifi district, Kenya.
In Nov 2002 we performed WHO cluster-sample surveys of >200 children scheduled for vaccination before or after introduction of pentavalent vaccine. In Mar 2004 we conducted a simple random sample (SRS) survey of 204 children aged 9-23 months. Coverage was estimated by inverse Kaplan-Meier survival analysis of vaccine-card and mothers' recall data and corroborated by reviewing administrative records from national and provincial vaccine stores. The contribution to timely immunization of distance from clinic, seasonal rainfall, mother's age, and family size was estimated by a proportional hazards model.
Immunization coverage for three DTP and pentavalent doses was 100% before and 91% after pentavalent vaccine introduction, respectively. By SRS survey, coverage was 88% for three pentavalent doses. The median age at first, second and third vaccine dose was 8, 13 and 18 weeks. Vials dispatched to Kilifi District during 2001-2003 would provide three immunizations for 92% of the birth cohort. Immunization rate ratios were reduced with every kilometre of distance from home to vaccine clinic (HR 0.95, CI 0.91-1.00), rainy seasons (HR 0.73, 95% CI 0.61-0.89) and family size, increasing progressively up to 4 children (HR 0.55, 95% CI 0.41-0.73).
Vaccine coverage was high before and after introduction of pentavalent vaccine, but most doses were given late. Coverage is limited by seasonal factors and family size.
肯尼亚于2001年11月引入了一种包含白喉、破伤风、百日咳、B型流感嗜血杆菌和乙肝病毒抗原的五价疫苗,并加强了免疫服务。我们估计了肯尼亚基利菲区引入该疫苗前后的免疫覆盖率、疫苗接种及时性以及未接种疫苗的风险因素。
2002年11月,我们对200多名计划在引入五价疫苗之前或之后接种疫苗的儿童进行了世卫组织整群抽样调查。2004年3月,我们对204名9至23个月大的儿童进行了简单随机抽样(SRS)调查。通过对疫苗接种卡和母亲回忆数据进行逆Kaplan-Meier生存分析来估计覆盖率,并通过查阅国家和省级疫苗储存的行政记录进行佐证。通过比例风险模型估计距离诊所的远近、季节性降雨、母亲年龄和家庭规模对及时免疫接种的影响。
引入五价疫苗之前,三针白喉、破伤风、百日咳疫苗和五价疫苗的免疫覆盖率分别为100%和91%。通过SRS调查,三针五价疫苗的覆盖率为88%。第一针、第二针和第三针疫苗接种的中位年龄分别为8周、13周和18周。2001年至2003年期间分发到基利菲区的疫苗瓶可为92%的出生队列提供三次免疫接种。离家到疫苗诊所每增加一公里,免疫接种率比值降低(风险比0.95,可信区间0.91 - 1.00),雨季时降低(风险比0.73,95%可信区间0.61 - 0.89),家庭规模每增加到4个孩子,免疫接种率比值也降低(风险比0.55,95%可信区间0.41 - 0.73)。
引入五价疫苗前后疫苗覆盖率都很高,但大多数剂量的接种时间较晚。覆盖率受到季节因素和家庭规模的限制。